1. The multifaceted role of autophagy in cancer and the microenvironment
   Hendrik Folkerts et al, 2018, Med Res Rev CrossRef
2. Long noncoding RNAs as biotargets in cisplatin-based drug resistance
   Nadiah Abu et al, 2018, Future Oncology CrossRef
3. Ethyl pyruvate protects against Salmonella intestinal infection in mice through down-regulation of pro-inflammatory factors and inhibition of TLR4/MAPK pathway
   Na Dong et al, 2019, International Immunopharmacology CrossRef
4. Interference with SMO increases chemotherapy drug sensitivity of A2780/DDP cells by inhibiting the Hh/Gli signaling pathway
   Shihong Ma et al, 2020, J Cell Biochem CrossRef
5. HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression
   Xiu Lei et al, 2020, Cellular Signalling CrossRef
6. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.
   Yanjie Liu et al, 2020, Cancer Cell Int CrossRef
7. Tim-3 finds its place in the cancer immunotherapy landscape.
   Nandini Acharya et al, 2020, J Immunother Cancer CrossRef
8. Necrosis of osteosarcoma cells induces the production and release of high-mobility group box 1 protein.
   Jiyu Yang et al, 2018, Exp Ther Med CrossRef
9. Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy.
   Lin Run et al, 2021, Endocrine CrossRef
10. Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis
    Christian Bailly et al, 2020, Life Sciences CrossRef
11. Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential
    Reem Saleh et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
12. Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis
    Chao-Qun Wang et al, 2020, Sci Rep CrossRef
13. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p
    Jinming Zhu et al, 2020, Technol Cancer Res Treat CrossRef
14. Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma
    Brady Anderson et al, 2021, Onco CrossRef
15. Matrine exerts antitumor activity in cervical cancer by protective autophagy via the Akt/mTOR pathway in vitro and in vivo
    Fan Zhang et al, 2022, Oncol Lett CrossRef
16. Structure and Functions of T-cell Immunoglobulin-domain and Mucin- domain Protein 3 in Cancer
    Xinjie Lu, 2022, CMC CrossRef
17. Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression
    Nadia Hindi et al, 2023, IJMS CrossRef
18. Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer
    Franziska Böttger et al, 2024, Molecular Oncology CrossRef
19. null
    Clifford M. Csizmar et al, 2024 CrossRef
20. Advances in research on autophagy mechanisms in resistance to endometrial cancer treatment
    Jingjing Ji et al, 2024, Front. Oncol. CrossRef
21. Recent Advances on Pt-Based Compounds for Theranostic Applications
    Giulia Ferrari et al, 2024, Molecules CrossRef
22. The Multidirectional Effect of Azelastine Hydrochloride on Cervical Cancer Cells
    Ewa Trybus et al, 2022, IJMS CrossRef